EN HU

Bereczki Ilona

Name: Bereczki Ilona
Other profiles: MTMT

Publication list

Uploaded publications:
55
Publications in DEA:
55
OA:
24
Date range:
2006-2025
2025
1.
Kelemen, V., Bege, M., Debreczeni, N., Bereczki, I., Bényei, A., Herczegh, P., Borbás, A.: Stereoselective Synthesis of 1,2-cis-alpha-Glycosyl Thiols and Trehalose-Type alpha,alpha'-Thiodisaccharides by Cryo Thiol-Ene Photocoupling - Thio-Click Reaction in Frozen State.
Chem.-Eur. J. [Epub ahead of print], 1-10, (article identifier: 202500104), 2025.
Journal metrics:
Q2 Catalysis (2024)
Q1 Chemistry (miscellaneous) (2024)
Q1 Organic Chemistry (2024)
2.
Bege, M., Lovas, M., Priksz, D., Bernát, B., Bereczki, I., Kattoub, R. G., Kajtár, R., Eskeif, S., Novák, L., Hodek, J., Weber, J., Herczegh, P., Lekli, I., Borbás, A.: Synthesis, H2S releasing properties, antiviral and antioxidant activities and acute cardiac effects of nucleoside 5'-dithioacetates.
Sci Rep. 15 (1), 2876-2881, 2025.
Journal metrics:
Q1 Multidisciplinary (2024)
3.
Bege, M., Leiner, K., Lovas, M., Pető, R., Bereczki, I., Hodek, J., Weber, J., Kuczmog, A., Borbás, A.: Synthesis of 3'-modified xylofuranosyl nucleosides bearing 5'-silyl or -butyryl groups and their antiviral effect against RNA viruses.
Eur. J. Pharm. Sci. 209, 1-12, (article identifier: 107107), 2025.
Journal metrics:
Q1 Pharmaceutical Science (2024)
2024
4.
Tósaki, Á., Szabó, Z., Király, J., Lőrincz, E. B., Vass, V., Tánczos, B., Bereczki, I., Herczegh, P., Remenyik, É., Tósaki, Á., Szabó, E.: A new cannabigerol derivative, LE-127/2, induces autophagy mediated cell death in human cutaneous melanoma cells.
Eur. J. Pharm. Sci. 203, 1-15, (article identifier: 106920), 2024.
Journal metrics:
Q1 Pharmaceutical Science
5.
Tánczos, B., Vass, V., Szabó, E., Lovas, M., Kattoub, R. G., Bereczki, I., Borbás, A., Herczegh, P., Tósaki, Á.: Effects of H2S-donor ascorbic acid derivative and ischemia/reperfusion-induced injury in isolated rat hearts.
Eur. J. Pharm. Sci. 195, 1-15, (article identifier: 106721), 2024.
Journal metrics:
Q1 Pharmaceutical Science
2023
6.
Lőrincz, E. B., Herczeg, M., Houser, J., Rievajová, M., Kuki, Á., Malinovská, L., Naesens, L., Wimmerová, M., Borbás, A., Herczegh, P., Bereczki, I.: Amphiphilic Sialic Acid Derivatives as Potential Dual-Specific Inhibitors of Influenza Hemagglutinin and Neuraminidase.
Int. J. Mol. Sci. 24, 1-23, (article identifier: 17268), 2023.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
7.
Bege, M., Singh, V., Sharma, N., Debreczeni, N., Bereczki, I., Herczegh, P., Rathi, B., Singh, S., Borbás, A.: In vitro and in vivo antiplasmodial evaluation of sugar-modified nucleoside analogues.
Sci. Rep. 13 (1), 1-8, (article identifier: 12228), 2023.
Journal metrics:
D1 Multidisciplinary
8.
Lőrincz, E. B., Tóth, G., Spolárics, J., Herczeg, M., Hodek, J., Zupkó, I., Minorics, R., Ádám, D., Oláh, A., Zouboulis, C. C., Weber, J., Nagy, L., Ostorházi, E., Bácskay, I., Borbás, A., Herczegh, P., Bereczki, I.: Mannich-type modifications of (-)-cannabidiol and (-)-cannabigerol leading to new, bioactive derivatives.
Sci. Rep. 13 (1), 19618, (article identifier: 19618), 2023.
Journal metrics:
D1 Multidisciplinary
9.
Debreczeni, N., Hotzi, J., Bege, M., Lovas, M., Mező, E., Bereczki, I., Herczegh, P., Kiss, L., Borbás, A.: N-Fluoroalkylated Morpholinos - a New Class of Nucleoside Analogues.
Chem.-Eur. J. 29 (11), 1-16, (article identifier: 202203248), 2023.
Journal metrics:
Q2 Catalysis
Q1 Chemistry (miscellaneous)
Q1 Organic Chemistry
10.
Szőke, K., Kajtár, R., Gyöngyösi, A., Czompa, A., Fésüs, A., Lőrincz, E. B., Petróczi, D. F., Herczegh, P., Bak, I., Borbás, A., Bereczki, I., Lekli, I.: Pharmacological Evaluation of Newly Synthesized Cannabidiol Derivates on H9c2 Cells.
Antioxidants. 12 (9), 1-15, (article identifier: 1714), 2023.
Journal metrics:
Q1 Biochemistry
Q2 Cell Biology
Q1 Clinical Biochemistry
D1 Food Science
Q2 Molecular Biology
Q1 Physiology
11.
Vass, V., Szabó, E., Bereczki, I., Debreczeni, N., Borbás, A., Herczegh, P., Tósaki, Á.: Reperfusion-induced injury and the effects of the dithioacetate type hydrogen sulfide donor ibuprofen derivative, BM-88, in isolated rat hearts.
Eur. J. Pharm. Sci. 185, 1-14, (article identifier: 106449), 2023.
Journal metrics:
Q1 Pharmaceutical Science
12.
Bege, M., Herczeg, M., Bereczki, I., Debreczeni, N., Bényei, A., Herczegh, P., Borbás, A.: Triaza-tricyclanos - synthesis of a new class of tricyclic nucleoside analogues by stereoselective cascade cyclocondensation.
Org. Biomol. Chem. 21 (10), 2213-2219, 2023.
Journal metrics:
Q3 Biochemistry
Q2 Organic Chemistry
Q2 Physical and Theoretical Chemistry
2022
13.
Bereczki, I.: Glikopeptid antibiotikumok újragondolva - antivirális terápiás lehetőségek.
Gyógyszerészet. 66, 1-5, 2022.
14.
Erdélyi, L. J., Fenyvesi, F., Gál, B., Haimhoffer, Á., Vasvári, G., Budai, I., Gálné Remenyik, J., Bereczki, I., Fehér, P., Ujhelyi, Z., Bácskay, I., Vecsernyés, M., Kovács, R. L., Váradi, J.: Investigation of the Role and Effectiveness of Chitosan Coating on Probiotic Microcapsules.
Polymers. 14 (9), 1-16, (article identifier: 1664), 2022.
Journal metrics:
Q1 Chemistry (miscellaneous)
Q1 Polymers and Plastics
15.
Bereczki, I., Vimberg, V., Lőrincz, E. B., Papp, H., Nagy, L., Kéki, S., Batta, G., Mitrović, A., Kos, J., Zsigmond, Á., Hajdu, I., Lőrincz, Z., Bajusz, D., Petri, L., Hodek, J., Jakab, F., Keserű, G. M., Weber, J., Naesens, L., Herczegh, P., Borbás, A.: Semisynthetic teicoplanin derivatives with dual antimicrobial activity against SARS-CoV-2 and multiresistant bacteria.
Sci. Rep. 12 (1), 12-17, 2022.
Journal metrics:
D1 Multidisciplinary
16.
Bege, M., Kiss, A., Bereczki, I., Hodek, J., Polyák, L., Szemán-Nagy, G., Naesens, L., Weber, J., Borbás, A.: Synthesis and Anticancer and Antiviral Activities of C-2'-Branched Arabinonucleosides.
Int. J. Mol. Sci. 23 (20), 1-24, (article identifier: 12566), 2022.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
17.
Szűcs, Z., Bereczki, I., Fenyvesi, F., Herczegh, P., Ostorházi, E., Borbás, A.: Synthesis of an amphiphilic vancomycin aglycone derivative inspired by polymyxins: overcoming glycopeptide resistance in Gram-positive and Gram-negative bacteria in synergy with teicoplanin in vitro.
Sci. Rep. 12 (1), 1-14, (article identifier: 20921), 2022.
Journal metrics:
D1 Multidisciplinary
18.
Demeter, F., Bereczki, I., Borbás, A., Herczeg, M.: Synthesis of Four Orthogonally Protected Rare L-Hexose Thioglycosides from D-Mannose by C-5 and C-4 Epimerization.
Molecules. 27 (11), 1-35, (article identifier: 3422), 2022.
Journal metrics:
Q2 Analytical Chemistry
Q2 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
19.
Bereczki, I., Szűcs, Z., Batta, G., Nagy, T. M., Ostorházi, E., Kövér, K. E., Borbás, A., Herczegh, P.: The First Dimeric Derivatives of the Glycopeptide Antibiotic Teicoplanin.
Pharmaceuticals (Basel). 15 (1), 1-17, (article identifier: 77), 2022.
Journal metrics:
Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
2021
20.
Gyöngyösi, A., Verner, V., Bereczki, I., Kiss-Szikszai, A., Zilinyi, R., Tósaki, Á., Bak, I., Borbás, A., Herczegh, P., Lekli, I.: Basic Pharmacological Characterization of EV-34, a New H2S-Releasing Ibuprofen Derivative.
Molecules. 26 (3), 1-12, 2021.
Journal metrics:
Q2 Analytical Chemistry
Q2 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
21.
Kiss, A., Baksa, V., Tálas, L., Bege, M., Borbás, A., Bereczki, I., Bánfalvi, G., Szemán-Nagy, G.: MTT Test and Time-lapse Microscopy to Evaluate the Antitumor Potential of Nucleoside Analogues.
Anticancer Res. 41 (1), 137-149, 2021.
Journal metrics:
Q3 Cancer Research
Q2 Medicine (miscellaneous)
Q3 Oncology
22.
Bereczki, I., Papp, H., Kuczmog, A., Madai, M., Nagy, V., Agócs, A., Batta, G., Milánkovits, M., Ostorházi, E., Mitrović, A., Kos, J., Zsigmond, Á., Hajdú, I., Lőrincz, Z., Bajusz, D., Keserű, G. M., Hodek, J., Weber, J., Jakab, F., Herczegh, P., Borbás, A.: Natural Apocarotenoids and Their Synthetic Glycopeptide Conjugates Inhibit SARS-CoV-2 Replication.
Pharmaceuticals (Basel). 14 (11), 1-26, 2021.
Journal metrics:
Q1 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
23.
Mező, E., Herczeg, M., Demeter, F., Bereczki, I., Csávás, M., Borbás, A.: Systematic study of regioselective reductive ring opening reactions of 4,6-Ohalobenzylidene acetals of glucopyranosides.
J. Org. Chem. 86 (18), 12973-12987, 2021.
Journal metrics:
Q1 Organic Chemistry
24.
Le Thai, S., Páll, D., Rőth, E., Tran, T., Debreczeni, N., Bege, M., Bereczki, I., Ostorházi, E., Milánkovits, M., Herczegh, P., Borbás, A., Csávás, M.: The Very First Modification of Pleuromutilin and Lefamulin by Photoinitiated Radical Addition Reactions: synthesis and Antibacterial Studies.
Pharmaceutics. 13 (12), 1-21, 2021.
Journal metrics:
Q1 Pharmaceutical Science
25.
Debreczeni, N., Bege, M., Herczeg, M., Bereczki, I., Batta, G., Herczegh, P., Borbás, A.: Tightly linked morpholino-nucleoside chimeras: new, compact cationic oligonucleotide analogues.
Org. Biomol. Chem. 19, 8711-8721, 2021.
Journal metrics:
Q2 Biochemistry
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
DEENK University of Debrecen
© 2012 University of Debrecen